CD4 and CD8 T cell immune activation during chronic HIV infection: Roles of homeostasis, HIV, Type I IFN, and IL-7

Journal of Immunology

Volumn 186, Issue 4, 2011, Pages 2106-2116

  Catalfamo, Marta ^a   Wilhelm, Christopher ^a   Tcheung, Lueng ^a   Proschan, Michael ^a   Friesen, Travis ^a   Park, Jung Hyun ^b   Adelsberger, Joseph ^c   Baseler, Michael ^c   Maldarelli, Frank ^b   Davey, Richard ^a   Roby, Gregg ^a   Rehm, Catherine ^a   Lane, Clifford ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; ALPHA INTERFERON RECEPTOR 1; CYTOKINE; RECOMBINANT ALPHA INTERFERON; RECOMBINANT INTERLEUKIN 7; STAT1 PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSURVEILLANCE; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; MALE; MEMORY T LYMPHOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA ANALYSIS; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD; VIRUS PATHOGENESIS;

ADULT; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHRONIC DISEASE; COHORT STUDIES; FEMALE; G0 PHASE; HIV INFECTIONS; HOMEOSTASIS; HUMANS; INTERFERON TYPE I; INTERFERON-ALPHA; INTERLEUKIN-7; LYMPHOCYTE ACTIVATION; LYMPHOPENIA; MALE; MIDDLE AGED; PHOSPHORYLATION; RNA, VIRAL; STAT1 TRANSCRIPTION FACTOR; VIRAL LOAD;

EID: 79951825000     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002000     Document Type: Article

References (39)

1. Sachsenberg, N., A. S. Perelson, S. Yerly, G. A. Schockmel, D. Leduc, B. Hirschel, and L. Perrin. 1998. Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J. Exp. Med. 187: 1295-1303.
2. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373: 123-126.
3. Kovacs, J. A., R. A. Lempicki, I. A. Sidorov, J. W. Adelsberger, B. Herpin, J. A. Metcalf, I. Sereti, M. A. Polis, R. T. Davey, J. Tavel, et al. 2001. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J. Exp. Med. 194: 1731-1741.
4. Lempicki, R. A., J. A. Kovacs, M. W. Baseler, J. W. Adelsberger, R. L. Dewar, V. Natarajan, M. C. Bosche, J. A. Metcalf, R. A. Stevens, L. A. Lambert, et al. 2000. Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients. Proc. Natl. Acad. Sci. USA 97: 13778-13783.
5. Hazenberg, M. D., D. Hamann, H. Schuitemaker, and F. Miedema. 2000. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat. Immunol. 1: 285-289.
6. Catalfamo, M., M. Di Mascio, Z. Hu, S. Srinivasula, V. Thaker, J. Adelsberger, A. Rupert, M. Baseler, Y. Tagaya, G. Roby, et al. 2008. HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proc. Natl. Acad. Sci. USA 105: 19851-19856.
7. Surh, C. D., and J. Sprent. 2000. Homeostatic T cell proliferation: how far can T cells be activated to self-ligands? J. Exp. Med. 192: F9-F14.
8. Hakim, F. T., R. Cepeda, S. Kaimei, C. L. Mackall, N. McAtee, J. Zujewski, K. Cowan, and R. E. Gress. 1997. Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 90: 3789-3798.
9. Vrisekoop, N., R. van Gent, A. B. de Boer, S. A. Otto, J. C. Borleffs, R. Steingrover, J. M. Prins, T. W. Kuijpers, T. F. Wolfs, S. P. Geelen, et al. 2008. Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging. J. Immunol. 181: 1573-1581.
10. Connors, M., J. A. Kovacs, S. Krevat, J. C. Gea-Banacloche, M. C. Sneller, M. Flanigan, J. A. Metcalf, R. E. Walker, J. Falloon, M. Baseler, et al. 1997. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat. Med. 3: 533-540.
11. Gea-Banacloche, J. C., E. E. Weiskopf, C. Hallahan, J. C. López Bernaldo de Quirós, M. Flanigan, J. M. Mican, J. Falloon, M. Baseler, R. Stevens, H. C. Lane, and M. Connors. 1998. Progression of human immunodeficiency virus disease is associated with increasing disruptions within the CD4+ T cell receptor repertoire. J. Infect. Dis. 177: 579-585.
12. Puel, A., S. F. Ziegler, R. H. Buckley, and W. J. Leonard. 1998. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat. Genet. 20: 394-397.
13. Mazzucchelli, R., and S. K. Durum. 2007. Interleukin-7 receptor expression: intelligent design. Nat. Rev. Immunol. 7: 144-154.
14. Gadina, M., D. Hilton, J. A. Johnston, A. Morinobu, A. Lighvani, Y. J. Zhou, R. Visconti, and J. J. O'Shea. 2001. Signaling by type I and II cytokine receptors: ten years after. Curr. Opin. Immunol. 13: 363-373.
15. Lu, N., Y. H. Wang, Y. H. Wang, K. Arima, S. Hanabuchi, and Y. J. Liu. 2009. TSLP and IL-7 use two different mechanisms to regulate human CD4+ T cell homeostasis. J. Exp. Med. 206: 2111-2119.
16. Boasso, A., and G. M. Shearer. 2008. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin. Immunol. 126: 235-242.
17. Preble, O. T., A. H. Rook, G. V. Quinnan, J. Vilcek, R. M. Friedman, R. Steis, E. P. Gelmann, and J. A. Sonnabend. 1984. Role of interferon in AIDS. Ann. N. Y. Acad. Sci. 437: 65-75.
18. Boasso, A., A. W. Hardy, A. L. Landay, J. L. Martinson, S. A. Anderson, M. J. Dolan, M. Clerici, and G. M. Shearer. 2008. PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes. Clin. Immunol. 129: 132-144.
19. Herbeuval, J. P., A. W. Hardy, A. Boasso, S. A. Anderson, M. J. Dolan, M. Dy, and G. M. Shearer. 2005. Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. USA 102: 13974-13979.
20. Boasso, A., J. P. Herbeuval, A. W. Hardy, S. A. Anderson, M. J. Dolan, D. Fuchs, and G. M. Shearer. 2007. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 109: 3351-3359.
21. Lane, H. C., J. A. Kovacs, J. Feinberg, B. Herpin, V. Davey, R. Walker, L. Deyton, J. A. Metcalf, M. Baseler, N. Salzman, et al. 1988. Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma. Lancet 2: 1218-1222.
22. Bosinger, S. E., Q. Li, S. N. Gordon, N. R. Klatt, L. Duan, L. Xu, N. Francella, A. Sidahmed, A. J. Smith, E. M. Cramer, et al. 2009. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J. Clin. Invest. 119: 3556-3572.
23. Jacquelin, B., V. Mayau, B. Targat, A. S. Liovat, D. Kunkel, G. Petitjean, M. A. Dillies, P. Roques, C. Butor, G. Silvestri, et al. 2009. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J. Clin. Invest. 119: 3544-3555.
24. Wang, J., Q. Lin, H. Langston, and M. D. Cooper. 1995. Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells. Immunity 3: 475-484.
25. Sato, T., N. Onai, H. Yoshihara, F. Arai, T. Suda, and T. Ohteki. 2009. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat. Med. 15: 696-700.
26. Roederer, M. 2001. Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 45: 194-205. (Pubitemid 33064141)
27. Polis, M. A., I. A. Sidorov, C. Yoder, S. Jankelevich, J. Metcalf, B. U. Mueller, M. A. Dimitrov, P. Pizzo, R. Yarchoan, and D. S. Dimitrov. 2001. Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy. Lancet 358: 1760-1765.
28. Phillips, A. N., F. C. Lampe, C. J. Smith, A. M. Geretti, A. Rodger, R. K. Lodwick, V. Cambiano, R. Tsintas, and M. A. Johnson. 2010. Ongoing changes in HIV RNA levels during untreated HIV infection: implications for CD4 cell count depletion. AIDS 24: 1561-1567.
29. Paiardini, M., B. Cervasi, H. Albrecht, A. Muthukumar, R. Dunham, S. Gordon, H. Radziewicz, G. Piedimonte, M. Magnani, M. Montroni, et al. 2005. Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. J. Immunol. 174: 2900-2909. (Pubitemid 40279708)
30. Douek, D. C. 2003. Disrupting T-cell homeostasis: how HIV-1 infection causes disease. AIDS Rev. 5: 172-177. (Pubitemid 37336634)
31. Lane, H. C. 2010. Pathogenesis of HIV infection: total CD4+ T-cell pool, immune activation, and inflammation. Top. HIV Med. 18: 2-6.
32. Surh, C. D., and J. Sprent. 2008. Homeostasis of naive and memory T cells. Immunity 29: 848-862.
33. Asquith, B., J. A. Borghans, V. V. Ganusov, and D. C. Macallan. 2009. Lymphocyte kinetics in health and disease. Trends Immunol. 30: 182-189.
34. Foulds, K. E., L. A. Zenewicz, D. J. Shedlock, J. Jiang, A. E. Troy, and H. Shen. 2002. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 168: 1528-1532. (Pubitemid 34135743)
35. Green, D. R., and R. K. Gershon. 1982. Hyperimmunity and the decision to be intolerant. Ann. N. Y. Acad. Sci. 392: 318-329.
36. Douek, D. 2007. HIV disease progression: immune activation, microbes, and a leaky gut. Top. HIV Med. 15: 114-117.
37. Lane, H. C. 1994. Interferons in HIV and related diseases. AIDS 8(Suppl. 3): S19-S23. (Pubitemid 24330440)
38. Lempicki, R. A., M. A. Polis, J. Yang, M. McLaughlin, C. Koratich, D. W. Huang, B. Fullmer, L. Wu, C. A. Rehm, H. Masur, et al. 2006. Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons. J. Infect. Dis. 193: 1172-1177.
39. Kuller, L. H., R. Tracy, W. Belloso, S. De Wit, F. Drummond, H. C. Lane, B. Ledergerber, J. Lundgren, J. Neuhaus, D. Nixon, et al; INSIGHT SMART Study Group. 2008. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 5: e203.